Exponential increase of glutamic acid decarboxylase (GAD) antibody titer after initiating and stopping insulin in a patient with slowly progressive type 1 diabetes.

Nishimura, Akihiro; Nagasawa, Kaoru; Okubo, Minoru; Kobayashi, Tetsuro; Mori, Yasumichi

Nishimura, Akihiro; Nagasawa, Kaoru; Okubo, Minoru; Kobayashi, Tetsuro; Mori, Yasumichi.

Affiliation

Nishimura A; Department of Endocrinology and Metabolism Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.

Endocr J ; 62(12): 1077-82, 2015.

Article in En | MEDLINE | ID: mdl-26440526

Subject(s)

Autoantibodies/blood; Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 1/immunology; Glutamate Decarboxylase/immunology; Insulin/administration & dosage; Blood Glucose/analysis; Diabetes Mellitus, Type 1/genetics; Fasting; Female; Genetic Predisposition to Disease; Glucose Tolerance Test; Glycated Hemoglobin/analysis; Haplotypes; Histocompatibility Antigens Class II/genetics; Humans; Hypoglycemia/chemically induced; Insulin Glargine/administration & dosage; Japan; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Diabetes Mellitus, Type 1 / Glutamate Decarboxylase / Insulin Limits: Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Endocr J Journal subject: ENDOCRINOLOGIA Year: 2015 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google